SRNE

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SRNE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/11/04	06:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/10/28	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/09/13	10:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/29	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/08	05:15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/08/01	19:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/07/13	19:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/22	06:25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/21	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/15	22:44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/06/05	22:00	GlobeNewswire Inc.	Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/19	19:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/16	04:18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/16	01:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/13	06:29	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/09	19:03	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/05/03	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/21	06:28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/21	01:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/12	21:51	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/11	06:23	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/04/11	04:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/31	19:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/21	08:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/20	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/11	01:22	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/03/09	04:20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	23:25	AllPennyStocks.com	Bankruptcy Court Approval Causes Premarket Buying Pressure	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	07:57	PR Newswire (US)	Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case	NASDAQ:SRNE	Sorrento Therapeutics Inc
2023/02/22	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRNE	Sorrento Therapeutics Inc